Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 7/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.31 |
| ▸ | TP53 | P04637 | 3/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17366363 | 0.88 | THRB (0.35) | TSHRHPGDTHRBALDH1A1TP53 | |
| SCHEMBL19071160 | 0.87 | TSHR (0.33) | TSHRHPGDTHRB | |
| SCHEMBL47327 | 0.87 | ALDH1A1 (0.36) | TSHRHPGDTHRBALDH1A1TP53 | |
| SCHEMBL22317191 | 0.85 | THRB (0.35) | TSHRHPGDTHRBALDH1A1TP53 | |
| SCHEMBL19071296 | 0.85 | TSHR (0.32) | TSHRHPGDTHRB | |
| SCHEMBL22373675 | 0.83 | THRB (0.36) | TSHRHPGDTHRBALDH1A1TP53 | |
| SCHEMBL24702088 | 0.83 | TSHR (0.38) | TSHRHPGDTHRBALDH1A1TP53 | |
| SCHEMBL22317194 | 0.83 | TSHR (0.33) | TSHRHPGDTHRBALDH1A1TP53 | |
| SCHEMBL12777816 | 0.83 | THRB (0.32) | TSHRHPGDTHRBALDH1A1TP53 | |
| SCHEMBL22608653 | 0.82 | TSHR (0.30) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3778657-A1 | CURABLE COMPOSITION, CURED PRODUCT OF SAME, AND ELECTRONIC COMPONENT COMPRISING SAID CURED PRODUCT | Taiyo Ink Mfg. Co., Ltd. (JP) | 2021-02-17 | — | — | EP | disclosed |
| US-20190002617-A1 | RADICALLY CURABLE COMPOSITION AND CURED PRODUCT THEREOF | KANEKA CORPORATION (JP) | 2019-01-03 | — | — | US | disclosed |
| US-9708424-B2 | (Meth)acryloyl-terminated polyisobutylene polymer, method for producing the same, and active energy ray-curable composition | KANEKA CORPORATION (JP) | 2017-07-18 | — | — | US | disclosed |
| US-20170051093-A1 | (METH)ACRYLOYL-TERMINATED POLYISOBUTYLENE POLYMER, METHOD FOR PRODUCING THE SAME, AND ACTIVE ENERGY RAY-CURABLE COMPOSITION | KANEKA CORP (JP) | 2017-02-23 | — | — | US | disclosed |
| US-9512247-B2 | (Meth)acryloyl-terminated polyisobutylene polymer, method for producing the same, and active energy ray-curable composition | KANEKA CORPORATION (JP) | 2016-12-06 | — | — | US | disclosed |
| US-20140243444-A1 | (METH)ACRYLOYL-TERMINATED POLYISOBUTYLENE POLYMER, METHOD FOR PRODUCING THE SAME, AND ACTIVE ENERGY RAY-CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2014-08-28 | — | — | US | disclosed |
| EP-2762506-A1 | (METH)ACRYLOYL-TERMINATED POLYISOBUTYLENE POLYMER, METHOD FOR PRODUCING SAME, AND ACTIVE ENERGY RAY-CURABLE COMPOSITION | Kaneka Corporation (JP) | 2014-08-06 | — | — | EP | disclosed |